GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury
- 15 November 2014
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 307 (10) , L735-L745
Abstract
Although AMP-activated protein kinase (AMPK) is involved in regulating carbohydrate and lipid metabolism, activated AMPK also plays an anti-inflammatory role in many cell populations. However, despite the ability of AMPK activation to diminish the severity of inflammatory responses, previous studies have found that AMPK activity is diminished in LPS-treated neutrophils and also in lungs of mice with LPS-induced acute lung injury (ALI). Since GSK3β participates in regulating AMPK activity, we examined potential roles for GSK3β in modulating LPS-induced activation of neutrophils and macrophages and in influencing severity of ALI. We found that GSK3β-dependent phosphorylation of T479-AMPK was associated with pT172 dephosphorylation and inactivation of AMPK following TLR4 engagement. GSK3β inhibitors BIO (6-bromoindirubin-3′-oxime), SB216763 , or siRNA knockdown of GSK3β, but not the PI3K/AKT inhibitor LY294002, prevented Thr172-AMPK dephosphorylation. Exposure to LPS resulted in rapid binding between IKKβ and AMPKα, and phosphorylation of S485-AMPK by IKKβ. These results suggest that IKKβ-dependent phosphorylation of S485-AMPK was an essential step in subsequent phosphorylation and inactivation AMPK by GSK3β. Inhibition of GSK3β activity delayed IκBα degradation and diminished expression of the proinflammatory TNF-α in LPS-stimulated neutrophils and macrophages. In vivo, inhibition of GSK3β decreased the severity of LPS-induced lung injury as assessed by development of pulmonary edema, production of TNF-α and MIP-2, and release of the alarmins HMGB1 and histone 3 in the lungs. These results show that inhibition of AMPK by GSK3β plays an important contributory role in enhancing LPS-induced inflammatory responses, including worsening the severity of ALI.Keywords
This publication has 66 references indexed in Scilit:
- AMP‐activated protein kinase enhances the phagocytic ability of macrophages and neutrophilsThe FASEB Journal, 2011
- Structure of mammalian AMPK and its regulation by ADPNature, 2011
- Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF-α and Cyclooxygenase-2The Journal of Immunology, 2009
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapyCancer Letters, 2009
- Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?Cancer Cell, 2008
- AMP-activated protein kinase signaling in metabolic regulationJournal of Clinical Investigation, 2006
- Metformin Prevents Endotoxin-Induced Liver Injury after Partial HepatectomyThe Journal of Pharmacology and Experimental Therapeutics, 2006
- AMPK: A Key Sensor of Fuel and Energy Status in Skeletal MusclePhysiology, 2006
- The renaissance of GSK3Nature Reviews Molecular Cell Biology, 2001
- Glycogen Synthase Kinase-3: Properties, Functions, and RegulationChemical Reviews, 2001